Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.
1969 - 1978
General Partner of Advent. Raj joined Advent in 2005, bringing over 20 years of experience as an entrepreneur and investor in the life sciences.
After an academic career in molecular medicine at Oxford University, Raj co-founded Oxford GlycoSciences which became listed on the LSE and NASDAQ. Following its sale to UCB-Celltech, he became Chairman of Chroma Therapeutics and of Galapagos nv, and a Director of Celldex Therapeutics before joining Advent. He has served on the Board of several portfolio Companies including Thiakis, Avila, EUSA and Cellnovo.
